Canada markets closed

Medicure Inc. (MPH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.0000+0.0400 (+4.17%)
At close: 12:28PM EDT
Full screen
Previous Close0.9600
Open1.0000
Bid1.0000 x 0
Ask1.0900 x 0
Day's Range1.0000 - 1.0000
52 Week Range0.8000 - 1.5000
Volume2,000
Avg. Volume3,557
Market Cap10.251M
Beta (5Y Monthly)0.90
PE Ratio (TTM)12.50
EPS (TTM)0.0800
Earnings DateNov 21, 2022 - Nov 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.

    This release is being issued in connection with the filing of an early warning report (the "Early Warning Report") pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding the change in the ownership and control of common shares (the "Common Shares") of Medicure Inc. (the "Issuer") by Dr. Albert D. Friesen ("Dr. Friesen"). The Issuer's head office address and Dr. Friesen's business address is 2-1250 Wav

  • CNW Group

    MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022

    Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2022.

  • CNW Group

    MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022

    Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the Q2 Financial Results on a Conference Call on August 25, 2022 at 8:30 am Eastern Time. The Q2 Financials will be filed after closing the day before.